Name | Number of supported studies | Average coverage | |
---|---|---|---|
endothelial cell | 19 studies | 26% ± 11% | |
capillary endothelial cell | 10 studies | 22% ± 6% | |
endothelial cell of artery | 7 studies | 25% ± 4% | |
goblet cell | 7 studies | 28% ± 9% | |
vein endothelial cell | 6 studies | 21% ± 6% | |
epithelial cell | 6 studies | 29% ± 12% | |
endothelial cell of lymphatic vessel | 6 studies | 23% ± 4% | |
neuron | 5 studies | 31% ± 16% | |
enterocyte | 5 studies | 24% ± 5% | |
endothelial cell of vascular tree | 5 studies | 21% ± 3% | |
squamous epithelial cell | 4 studies | 34% ± 19% | |
ciliated cell | 4 studies | 24% ± 8% | |
fibroblast | 4 studies | 26% ± 8% | |
GABAergic neuron | 3 studies | 24% ± 7% | |
enteroendocrine cell | 3 studies | 26% ± 6% | |
basal cell | 3 studies | 22% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
brain | 100% | 9340.96 | 2642 / 2642 | 100% | 102.15 | 705 / 705 |
esophagus | 100% | 5945.87 | 1445 / 1445 | 100% | 79.95 | 183 / 183 |
ovary | 100% | 5667.98 | 180 / 180 | 100% | 91.17 | 430 / 430 |
thymus | 100% | 4959.04 | 652 / 653 | 100% | 68.41 | 605 / 605 |
kidney | 100% | 3579.61 | 89 / 89 | 100% | 68.11 | 899 / 901 |
skin | 100% | 5004.59 | 1808 / 1809 | 100% | 68.98 | 471 / 472 |
stomach | 100% | 4227.27 | 359 / 359 | 100% | 112.22 | 285 / 286 |
intestine | 100% | 6980.39 | 966 / 966 | 100% | 118.84 | 525 / 527 |
uterus | 100% | 6576.50 | 170 / 170 | 99% | 60.65 | 456 / 459 |
lung | 100% | 5659.08 | 577 / 578 | 99% | 63.94 | 1148 / 1155 |
bladder | 100% | 5060.57 | 21 / 21 | 99% | 74.50 | 499 / 504 |
prostate | 100% | 4253.96 | 244 / 245 | 99% | 49.97 | 499 / 502 |
adrenal gland | 100% | 4814.15 | 258 / 258 | 99% | 83.82 | 227 / 230 |
breast | 100% | 6834.89 | 459 / 459 | 99% | 89.12 | 1103 / 1118 |
pancreas | 64% | 992.51 | 210 / 328 | 100% | 101.32 | 178 / 178 |
liver | 32% | 455.97 | 73 / 226 | 91% | 28.78 | 370 / 406 |
adipose | 100% | 7521.35 | 1204 / 1204 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 100% | 72.28 | 80 / 80 |
lymph node | 0% | 0 | 0 / 0 | 100% | 61.27 | 29 / 29 |
spleen | 100% | 4660.88 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 53.42 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 68.65 | 1 / 1 |
blood vessel | 100% | 5143.78 | 1333 / 1335 | 0% | 0 | 0 / 0 |
heart | 99% | 3229.91 | 856 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 99% | 6865.43 | 920 / 929 | 0% | 0 | 0 / 0 |
muscle | 96% | 2151.67 | 774 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0120041 | Biological process | positive regulation of macrophage proliferation |
GO_0071260 | Biological process | cellular response to mechanical stimulus |
GO_0048009 | Biological process | insulin-like growth factor receptor signaling pathway |
GO_0043330 | Biological process | response to exogenous dsRNA |
GO_0030878 | Biological process | thyroid gland development |
GO_0032872 | Biological process | regulation of stress-activated MAPK cascade |
GO_0030509 | Biological process | BMP signaling pathway |
GO_0006468 | Biological process | protein phosphorylation |
GO_0070374 | Biological process | positive regulation of ERK1 and ERK2 cascade |
GO_1904262 | Biological process | negative regulation of TORC1 signaling |
GO_0019233 | Biological process | sensory perception of pain |
GO_0042473 | Biological process | outer ear morphogenesis |
GO_0038133 | Biological process | ERBB2-ERBB3 signaling pathway |
GO_1904355 | Biological process | positive regulation of telomere capping |
GO_0042552 | Biological process | myelination |
GO_0000165 | Biological process | MAPK cascade |
GO_0072584 | Biological process | caveolin-mediated endocytosis |
GO_0090170 | Biological process | regulation of Golgi inheritance |
GO_0071276 | Biological process | cellular response to cadmium ion |
GO_0051403 | Biological process | stress-activated MAPK cascade |
GO_0006351 | Biological process | DNA-templated transcription |
GO_0070371 | Biological process | ERK1 and ERK2 cascade |
GO_0060425 | Biological process | lung morphogenesis |
GO_0060324 | Biological process | face development |
GO_0051216 | Biological process | cartilage development |
GO_0042770 | Biological process | signal transduction in response to DNA damage |
GO_0098792 | Biological process | xenophagy |
GO_0070849 | Biological process | response to epidermal growth factor |
GO_0051493 | Biological process | regulation of cytoskeleton organization |
GO_0060440 | Biological process | trachea formation |
GO_0038083 | Biological process | peptidyl-tyrosine autophosphorylation |
GO_0008286 | Biological process | insulin receptor signaling pathway |
GO_0048538 | Biological process | thymus development |
GO_0051973 | Biological process | positive regulation of telomerase activity |
GO_0061308 | Biological process | cardiac neural crest cell development involved in heart development |
GO_0016310 | Biological process | phosphorylation |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0031663 | Biological process | lipopolysaccharide-mediated signaling pathway |
GO_2000641 | Biological process | regulation of early endosome to late endosome transport |
GO_0034614 | Biological process | cellular response to reactive oxygen species |
GO_0060020 | Biological process | Bergmann glial cell differentiation |
GO_0050804 | Biological process | modulation of chemical synaptic transmission |
GO_0070498 | Biological process | interleukin-1-mediated signaling pathway |
GO_0010759 | Biological process | positive regulation of macrophage chemotaxis |
GO_1904417 | Biological process | positive regulation of xenophagy |
GO_0071356 | Biological process | cellular response to tumor necrosis factor |
GO_0035556 | Biological process | intracellular signal transduction |
GO_0014044 | Biological process | Schwann cell development |
GO_0034198 | Biological process | cellular response to amino acid starvation |
GO_0006915 | Biological process | apoptotic process |
GO_0031281 | Biological process | positive regulation of cyclase activity |
GO_0030278 | Biological process | regulation of ossification |
GO_0032212 | Biological process | positive regulation of telomere maintenance via telomerase |
GO_0030641 | Biological process | regulation of cellular pH |
GO_0098978 | Cellular component | glutamatergic synapse |
GO_0005856 | Cellular component | cytoskeleton |
GO_0005788 | Cellular component | endoplasmic reticulum lumen |
GO_0005634 | Cellular component | nucleus |
GO_0005654 | Cellular component | nucleoplasm |
GO_0005770 | Cellular component | late endosome |
GO_0005886 | Cellular component | plasma membrane |
GO_0005739 | Cellular component | mitochondrion |
GO_0005769 | Cellular component | early endosome |
GO_0005794 | Cellular component | Golgi apparatus |
GO_0005737 | Cellular component | cytoplasm |
GO_0005901 | Cellular component | caveola |
GO_0005635 | Cellular component | nuclear envelope |
GO_0005925 | Cellular component | focal adhesion |
GO_0005829 | Cellular component | cytosol |
GO_0031143 | Cellular component | pseudopodium |
GO_0140297 | Molecular function | DNA-binding transcription factor binding |
GO_0042802 | Molecular function | identical protein binding |
GO_0005524 | Molecular function | ATP binding |
GO_0001784 | Molecular function | phosphotyrosine residue binding |
GO_0004707 | Molecular function | MAP kinase activity |
GO_0106310 | Molecular function | protein serine kinase activity |
GO_0019902 | Molecular function | phosphatase binding |
GO_0004674 | Molecular function | protein serine/threonine kinase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | MAPK3 |
Protein name | Mitogen-activated protein kinase 3 (MAP kinase 3) (MAPK 3) (EC 2.7.11.24) (ERT2) (Extracellular signal-regulated kinase 1) (ERK-1) (Insulin-stimulated MAP2 kinase) (MAP kinase isoform p44) (p44-MAPK) (Microtubule-associated protein 2 kinase) (p44-ERK1) Mitogen-activated protein kinase (EC 2.7.11.24) mitogen-activated protein kinase (EC 2.7.11.24) |
Synonyms | ERK1 PRKM3 hCG_1983753 |
Description | FUNCTION: Serine/threonine kinase which acts as an essential component of the MAP kinase signal transduction pathway . MAPK1/ERK2 and MAPK3/ERK1 are the 2 MAPKs which play an important role in the MAPK/ERK cascade. They participate also in a signaling cascade initiated by activated KIT and KITLG/SCF. Depending on the cellular context, the MAPK/ERK cascade mediates diverse biological functions such as cell growth, adhesion, survival and differentiation through the regulation of transcription, translation, cytoskeletal rearrangements. The MAPK/ERK cascade also plays a role in initiation and regulation of meiosis, mitosis, and postmitotic functions in differentiated cells by phosphorylating a number of transcription factors. About 160 substrates have already been discovered for ERKs. Many of these substrates are localized in the nucleus, and seem to participate in the regulation of transcription upon stimulation. However, other substrates are found in the cytosol as well as in other cellular organelles, and those are responsible for processes such as translation, mitosis and apoptosis. Moreover, the MAPK/ERK cascade is also involved in the regulation of the endosomal dynamics, including lysosome processing and endosome cycling through the perinuclear recycling compartment (PNRC); as well as in the fragmentation of the Golgi apparatus during mitosis. The substrates include transcription factors (such as ATF2, BCL6, ELK1, ERF, FOS, HSF4 or SPZ1), cytoskeletal elements (such as CANX, CTTN, GJA1, MAP2, MAPT, PXN, SORBS3 or STMN1), regulators of apoptosis (such as BAD, BTG2, CASP9, DAPK1, IER3, MCL1 or PPARG), regulators of translation (such as EIF4EBP1) and a variety of other signaling-related molecules (like ARHGEF2, DEPTOR, FRS2 or GRB10) . Protein kinases (such as RAF1, RPS6KA1/RSK1, RPS6KA3/RSK2, RPS6KA2/RSK3, RPS6KA6/RSK4, SYK, MKNK1/MNK1, MKNK2/MNK2, RPS6KA5/MSK1, RPS6KA4/MSK2, MAPKAPK3 or MAPKAPK5) and phosphatases (such as DUSP1, DUSP4, DUSP6 or DUSP16) are other substrates which enable the propagation the MAPK/ERK signal to additional cytosolic and nuclear targets, thereby extending the specificity of the cascade. . |
Accessions | ENST00000395202.5 [P27361-2] Q9BWJ1 E9PJF0 ENST00000478356.5 ENST00000395199.7 [P27361-3] E9PQW4 ENST00000395200.5 H0YEX6 ENST00000484663.5 ENST00000322266.9 [P27361-2] P27361 ENST00000481230.1 H0YDH9 ENST00000490298.5 ENST00000461737.5 ENST00000263025.9 [P27361-1] E9PBK7 A1QJE5 L7RXH5 E9PRH7 ENST00000466521.5 |